Kidney International Reports · 2018 · 43 citations · 18 references
MedicineHealth PolicyNephrologyDialysisHealth InsuranceKidney TransplantationChronic HemodialysisChronic Kidney DiseaseEnd-stage Kidney Disease CareMortality AnalysisRenal DiseaseChronic Kidney Disease EpidemiologyChronic Kidney Disease ManagementChronic Kidney Disease PolicyEnd-stage Kidney Disease ManagementKidney Replacement TherapyNational Health InsuranceOverall Mortality
Introduction Despite a systematic increase in the coverage of patients with end-stage renal disease (ESRD) who have received dialytic therapies and transplantation over the past 2 decades, the Mexican health system currently still does not have a program to provide full coverage of ESRD. Our aim was to analyze mortality in patients with ESRD without health insurance. Methods This was a prospective cohort study of 850 patients with advanced chronic kidney disease (CKD). Risk factors associated with death were calculated using a Cox's proportional hazards model. We used the statistical package SPSS version 22.0 for data analysis. Results The mean age of patients was 44.8 ± 17.2 years old. At the time of hospital admission, 87.6% of the population did not have a social security program to cover the cost of renal replacement treatment, and 91.3% of families had an income below US$300 per month. During the 3 years of the study, 28.8% of the cohort patients were enrolled in 1 of Mexico's social security programs. The 3-year mortality rate was of 56.7% among patients without access to health insurance, in contrast to 38.2% of patients who had access to a social security program that provided access to renal replacement therapy ( P < 0.001). Risk factor analysis revealed that not having health insurance increased mortality (risk ratio: 2.64, 95% confidence intervals: 1.84−3.79; P = 0.001). Conclusion Mexico needs a coordinated National Kidney Health and Treatment Program. A program of this nature should provide the basis for an appropriate educational and intervention strategy for early detection, prevention, and treatment of patients with advanced chronic kidney disease.
18
Diabetes and Cause-Specific Mortality in Mexico City
New England Journal of Medicine · 2016 · 282 citations · Full text